Less-intensive drug combination is more effective in treating acute myeloid leukemia, clinical trial finds
2 sources·Updated September 3, 2026
Covered by 2 sources
- News-Medical·1d agoNewly diagnosed AML patients benefit from less-intensive combination treatment
Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice as much time before treatment failed, the leukemia…
Read at News-Medical → - Medical Xpress·1d agoLess-intensive drug combination is more effective in treating acute myeloid leukemia, clinical trial finds
Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice as much time before treatment failed, the leukemia…
Read at Medical Xpress →